UK:The new year 2021 starts with good news. The world top health institution “WHO” (World Health Organisation) allowed emergency use of the Pfizer-BioNTech vaccine, paving the way for countries worldwide to quickly approve its import and distribution.
Britain began its vaccination drive with the US-German vaccine on December 8, with the United States, Canada and EU countries following suit.
WHO said the Pfizer/BioNTech vaccine was the first to receive its “emergency validation” since the novel coronavirus first broke out in China a year ago.
WHO said it’s emergency use listing opens the way for regulators in different countries to approve the import and distribution of the vaccine.
It said it also enables UNICEF, which plays a key logistical role in distributing anti-Covid vaccines, and the Pan-American Health Organisation to procure the vaccine for countries that need it.
WHO convened its own experts and those from around the world to review the data on the Pfizer/BioNTech vaccine’s “safety, efficacy and quality,” weighing the benefits against the risks.
With this new year, the whole world is hoping for something good.
WHO urged all countries people to follow all health measures which has been prescribed by the WHO.
Apart from this, A new study conducted to evaluate mRNA-1273, a Covid-19 vaccine candidate, manufactured by Moderna, Inc, provides evidence that the vaccine can prevent symptomatic infection.
The preliminary findings of the study, published in The New England Journal of Medicine, stated the vaccine had demonstrated 94.1 per cent efficacy in preventing symptomatic Covid-19.
For the study, the researchers studied over 30,000 participants randomized to get the vaccine, or a placebo. 11 of those in the coronavirus vaccine group developed indicative Covid-19 compared to 185 participants who received the placebo.
WHO head said that war has not been ended yet.